The proceeds would be returned to shareholders through a $300-million share buyback, Smith & Nephew SNN.N said on Wednesday.
The unit, which primarily comprises a system for uterine surgery, generated $56 million in revenue in 2015, slightly more than 1 percent of the company’s total revenue.
The deal is expected to reduce adjusted earnings per share by less than 1 cent in 2016 and be neutral in 2017, Smith & Nephew said.
The Smith & Nephew deal follows Medtronic's investment in Mazor Robotics Ltd MZOR.TAMZOR.O announced earlier in the day. The company plans to buy up to 15 percent in the Israel-based surgical robotic guidance maker.
Shares in Smith and Nephew were down 1 percent at 1139 pence on the London Stock Exchange at 1228 GMT. Medtronic’s shares were unchanged in trading before the bell.
Reporting by Mamidipudi Soumithri in Bengaluru; Editing by Sriraj Kalluvila
Our Standards: The Thomson Reuters Trust Principles.